×
Metabolic Syndrome and Illness Severity Predict Relapse at 1-Year Follow-Up in Schizophrenia: The FACE-SZ Cohort PDF
$ 40.00
Metabolic Syndrome and Illness Severity Predict Relapse at 1-Year Follow-Up in Schizophrenia: The FACE-SZ Cohort PDF quantity
$ 40.00
×
Relapse Prevention in First-Episode Schizophrenia—Maintenance vs Intermittent Drug Treatment With Prodrome-Based Early Intervention: Results of a Randomized Controlled Trial Within the German Research Network on Schizophrenia PDF
$ 40.00
Relapse Prevention in First-Episode Schizophrenia—Maintenance vs Intermittent Drug Treatment With Prodrome-Based Early Intervention: Results of a Randomized Controlled Trial Within the German Research Network on Schizophrenia PDF quantity
$ 40.00
×
Efficacy of Controlled-Release Paroxetine in the Treatment of Late-Life Depression PDF
$ 40.00
Efficacy of Controlled-Release Paroxetine in the Treatment of Late-Life Depression PDF quantity
$ 40.00
×
A Prospective, Open-Label, Flexible-Dose Study of Quetiapine in the Treatment of Delirium PDF
$ 40.00
A Prospective, Open-Label, Flexible-Dose Study of Quetiapine in the Treatment of Delirium PDF quantity
$ 40.00
×
Secondary Trigeminal Neuralgia Due to Multiple Sclerosis in a Patient With Opioid Use Disorder Treated With Buprenorphine/Naloxone PDF
$ 40.00
Secondary Trigeminal Neuralgia Due to Multiple Sclerosis in a Patient With Opioid Use Disorder Treated With Buprenorphine/Naloxone PDF quantity
$ 40.00
×
Observational Evidence for Buprenorphine's Impact on Posttraumatic Stress Symptoms in Veterans With Chronic Pain and Opioid Use Disorder PDF
$ 40.00
Observational Evidence for Buprenorphine's Impact on Posttraumatic Stress Symptoms in Veterans With Chronic Pain and Opioid Use Disorder PDF quantity
$ 40.00
×
Intervention in Individuals at Ultra High Risk for Psychosis: A Review and Future Directions PDF
$ 40.00
Intervention in Individuals at Ultra High Risk for Psychosis: A Review and Future Directions PDF quantity
$ 40.00
×
Prolactin Levels in Schizophrenia and Schizoaffective Disorder Patients Treated With Clozapine, Olanzapine, Risperidone, or Haloperidol PDF
$ 40.00
Prolactin Levels in Schizophrenia and Schizoaffective Disorder Patients Treated With Clozapine, Olanzapine, Risperidone, or Haloperidol PDF quantity
$ 40.00
×
Mesiotemporal Disconnection and Hypoactivity in Klüver-Bucy Syndrome: Case Series and Literature Review PDF
$ 40.00
Mesiotemporal Disconnection and Hypoactivity in Klüver-Bucy Syndrome: Case Series and Literature Review PDF quantity
$ 40.00
×
AIDS/HIV Infection, Comorbid Psychiatric Illness, and Risk for Subsequent Suicide: A Nationwide Register Linkage Study PDF
$ 40.00
AIDS/HIV Infection, Comorbid Psychiatric Illness, and Risk for Subsequent Suicide: A Nationwide Register Linkage Study PDF quantity
$ 40.00
×
COVID-19–Related Stigma and Stress Among Doctors Working in the Private Sector During the COVID-19 Pandemic PDF
$ 40.00
COVID-19–Related Stigma and Stress Among Doctors Working in the Private Sector During the COVID-19 Pandemic PDF quantity
$ 40.00
×
Ranitidine, Metformin, and Topiramate: Managing Weight Gain in a Clozapine-Treated Patient With Schizoaffective Disorder PDF
$ 40.00
Ranitidine, Metformin, and Topiramate: Managing Weight Gain in a Clozapine-Treated Patient With Schizoaffective Disorder PDF quantity
$ 40.00
Coupon: Apply coupon
Update cart